While the immediate delisting threat has been resolved, traders should monitor DCOY's stock price closely throughout 2026-2027 as any drop below $1.00 during the Mandatory Panel Monitor period will trigger automatic delisting proceedings. The company's small $3M market cap and history of noncompliance suggest ongoing financial instability despite this temporary reprieve.
Price Chart
Executive Summary
Decoy Therapeutics Inc. (DCOY) has regained compliance with Nasdaq's $1.00 minimum bid price requirement after implementing a reverse stock split and trading above $1.00 for 10 consecutive business days, with the Nasdaq Hearings Panel confirming compliance on March 31, 2026. However, the company will remain under a Mandatory Panel Monitor until March 31, 2027, during which any future noncompliance could lead to delisting.
Key Facts
- Received Nasdaq noncompliance notice on December 31, 2025, for failing to maintain $1.00 minimum bid price for 30 consecutive days
- Implemented a reverse stock split effective March 6, 2026, began trading on split-adjusted basis March 9, 2026
- Granted exception period until March 20, 2026, to regain compliance after hearing with Nasdaq Hearings Panel on February 6, 2026
- Stock closed at $7.47 per share on March 20, 2026, demonstrating compliance by trading above $1.00 for 10 consecutive business days
- Nasdaq Hearings Panel confirmed compliance with all listing requirements on March 31, 2026
- Company subject to Mandatory Panel Monitor until March 31, 2027, with automatic delisting proceedings if it falls below $1.00 during this period
Financial Impact
The reverse stock split adjusted share count and increased share price from below $1.00 to $7.47, but no financial statement impact or fundraising was disclosed
Risk Factors
- Automatic delisting if share price falls below $1.00 at any point during the one-year Mandatory Panel Monitor period ending March 31, 2027
- History of noncompliance suggests fundamental business challenges that the reverse stock split does not address
- Small $3M market cap indicates high vulnerability to market fluctuations and potential liquidity issues
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-139145 |
| Document: dcoy-ex99_1.htm | 0001193125-26-139145 |
| Document: 0001193125-26-139145-index-headers.html | 0001193125-26-139145 |
| Document: 0001193125-26-139145-index.html | 0001193125-26-139145 |
| Document: 0001193125-26-139145.txt | 0001193125-26-139145 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 8d ago | EFFECT | $1.17 $0.9100 | ▼ −22.22% | ▼ −22.08% | $1.03 (−11.97%) |
Oct 7, 2026 20d ago | S-1 | $1.52 $1.23 | ▲ +19.08% | ▲ +18.80% | $1.03 (+32.24%) |
Sep 23, 2026 4w ago | 8-K | $3.11 $1.86 | ▲ +40.35% | ▲ +39.94% | $1.03 (+66.88%) |
Aug 4, 2026 12w ago | DEFA14A | $4.19 $3.60 | ▼ −14.08% | ▼ −14.43% | $1.03 (−75.42%) |
Jul 20, 2026 14w ago | EFFECT | $5.31 $3.74 | ▼ −29.50% | ▼ −29.10% | $1.03 (−80.58%) |
Jun 29, 2026 17w ago | 8-K | $9.59 $7.25 | ▲ +24.40% | ▲ +25.79% | $1.03 (+89.26%) |
Jun 25, 2026 17w ago | EFFECT | $5.92 $7.62 | ▲ +28.76% | ▲ +27.20% | $1.03 (−82.60%) |
Jun 4, 2026 20w ago | DEFA14A | $6.71 $5.90 | ▼ −12.07% | ▼ −9.52% | $1.03 (−84.65%) |
Apr 30, 2026 25w ago | 10-K/A | $6.05 $6.01 | ▼ −0.66% | ▼ −2.39% | $1.03 (−82.98%) |
Apr 2, 2026 29w ago | 8-K | $5.80 $5.84 | ▲ +0.69% | ▼ −2.93% | $1.03 (−82.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers